Icad, Inc.   Report issue

For profit Phase 2
Founded: Nashua NH United States (1984)

Organization Overview

First Clinical Trial
2021
NCT04681677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Icad, Inc.